Golden Dragon Holding Co (GDHC) 2.6000 $GDHC
Lawsuits Involving Gary M. Cohen, CannaPharmaRx, and Golden Dragon Holding Co. Have Been Resolved and Dismissed
Marketwired - Tue Mar 31, 7:58AM CDT
CannaPharmaRx, Inc. (OTCQB: CPMD), a New Jersey-based pharmaceutical company, announced today that the lawsuit filed in Florida on October 30, 2014 against CannaPharmaRx, Gary Herick, Gerry Crocker, Jim Smeeding, Mat Sherwood and Bo Liess by former CannaPharmaRx executive Gary M. Cohen has been resolved and dismissed. The parties amicably resolved their differences before any discovery occurred or before any decision by the court on the merits of any claims. Mr. Cohen had alleged various contract and employment related claims, as well as made allegations of what he believed had been corporate fraud, misappropriation, breach of fiduciary duty, and SEC or SOX violations. CannaPharmaRx and all the individuals who had been sued categorically denied all of Mr. Cohen's claims allegations, have maintained that the allegations were false, and were prepared to assert counterclaims of their own. As part of the parties' resolution, Mr. Cohen has agreed to retract his allegations.
CannaPharmaRx's stock ticker symbol changed to 'CPMD'
M2 - Tue Mar 24, 3:59AM CDT
CannaPharmaRx Inc (OTCQB:CPMD), a pharmaceutical company, announced on Monday that the company's shares will begin trading on the OTC Bulletin Board (OTC) under its new stock ticker symbol 'CPMD', effective immediately.
CannaPharmaRx names Christopher P. Schnittker as new CFO
M2 - Fri Feb 13, 6:02AM CST
CannaPharmaRx Inc (OTC:GDHC), a pharmaceutical company focussed on cannabinoid-based therapies, announced on Thursday that it has appointed Christopher P. Schnittker as chief financial officer of the company.
CannaPharmaRx Appoints Christopher P. Schnittker, CPA as Chief Financial Officer
Marketwired - Thu Feb 12, 8:04AM CST
CannaPharmaRx, Inc. (OTCQB: GDHC), the New Jersey-based pharmaceutical company, today announced that Christopher P. Schnittker, CPA has joined the company as its Chief Financial Officer, replacing Gary Herick, who will remain on the Board of Directors and as an employee in the role of Director of Finance. Gary's primary focus will remain on raising capital and investor relations.
CannaPharmaRx Teams Up With The Catalyst Agency to Build and Introduce CMR, a Longitudinal Cannabinoid Medicines Registry Database
ACCESSWIRE - Thu Jan 29, 6:00AM CST
CARNEYS POINT, NJ / ACCESSWIRE / January 29, 2015 / CannaPharmaRx, Inc. (OTCQB: GDHC), the New Jersey-based pharmaceutical company, is launching its proprietary Cannabinoid Medicines Registry(SM) program (CMR).
Cannapharmarx Engages Pharmaceutical Industry Drug Delivery Technology Expert Mario A. Gonzalez, Ph.D.
ACCESSWIRE - Wed Jan 28, 10:41AM CST
CARNEYS POINT, NJ / ACCESSWIRE / January 28, 2015 / CannaPharmaRx, Inc. (OTCQB: GDHC), the New Jersey-based pharmaceutical company, has announced the signing of a consultancy agreement with Mario A. Gonzalez, PhD, President and Chief Executive Officer of P'Kinetics International, Inc., a consulting firm specializing in pharmaceutical product development and pharmacokinetics research.
CannaPharmaRx names Mario A. Gonzalez as drug delivery technology expert
M2 - Wed Jan 28, 5:34AM CST
CannaPharmaRx Inc (OTC:GDHC), a pharmaceutical company focussed on cannabinoid-based therapies, announced on Tuesday the signing of a consultancy agreement with Mario A. Gonzalez, PhD, president and chief executive officer of P'Kinetics International Inc, a consulting firm specialising in pharmaceutical product development and pharmacokinetics research.
CannaPharmaRx names Thomas J. Della-Franco III as new financial controller
M2 - Mon Dec 08, 5:30AM CST
CannaPharmaRx Inc (OTC:GDHC), a pharmaceutical research and discovery company, announced on Friday that it has appointed Thomas J. Della-Franco III as financial controller.
CannapharmaRx (GDHC), Gary Herick sued for self-dealing by new plaintiff
PR Newswire - Tue Nov 25, 7:21AM CST
CannapharmaRx, (stock symbol GDHC), now tangled in a third lawsuit over legal ownership of the corporation. The new plaintiff alleges he is one of the original architects of the CannapharmaRx business and business plan, and claims he was wrongfully "cut out" of the stock ownership and opportunity to build the company.
CannapharmaRx, aka Golden Dragon Holding Company (stock symbol GDHC) Directors Gerald E Crocker, Robert "Bo" Liess, Mat Sherwood and James Smeeding are added to a lawsuit for Conspiracy and other counts
PR Newswire - Thu Nov 20, 2:44PM CST
The Board of Directors of CannapharmaRx, also known as Golden Dragon Holding Company, (stock symbol GDHC), have been added to multiple counts of the complaint filed by Gary M Cohen, the Founder, ex-President, Chief Operating Officer, and member of The Board of Directors, according to the National Association of Cannabis Pharmacy.
Lawsuits Involving Gary M. Cohen, CannaPharmaRx, and Golden Dragon Holding Co. Have Been Resolved and Dismissed
Marketwired - Tue Mar 31, 7:58AM CDT
CannaPharmaRx, Inc. (OTCQB: CPMD), a New Jersey-based pharmaceutical company, announced today that the lawsuit filed in Florida on October 30, 2014 against CannaPharmaRx, Gary Herick, Gerry Crocker, Jim Smeeding, Mat Sherwood and Bo Liess by former CannaPharmaRx executive Gary M. Cohen has been resolved and dismissed. The parties amicably resolved their differences before any discovery occurred or before any decision by the court on the merits of any claims. Mr. Cohen had alleged various contract and employment related claims, as well as made allegations of what he believed had been corporate fraud, misappropriation, breach of fiduciary duty, and SEC or SOX violations. CannaPharmaRx and all the individuals who had been sued categorically denied all of Mr. Cohen's claims allegations, have maintained that the allegations were false, and were prepared to assert counterclaims of their own. As part of the parties' resolution, Mr. Cohen has agreed to retract his allegations.
CannaPharmaRx's stock ticker symbol changed to 'CPMD'
M2 - Tue Mar 24, 3:59AM CDT
CannaPharmaRx Inc (OTCQB:CPMD), a pharmaceutical company, announced on Monday that the company's shares will begin trading on the OTC Bulletin Board (OTC) under its new stock ticker symbol 'CPMD', effective immediately.
CannaPharmaRx names Christopher P. Schnittker as new CFO
M2 - Fri Feb 13, 6:02AM CST
CannaPharmaRx Inc (OTC:GDHC), a pharmaceutical company focussed on cannabinoid-based therapies, announced on Thursday that it has appointed Christopher P. Schnittker as chief financial officer of the company.
CannaPharmaRx Appoints Christopher P. Schnittker, CPA as Chief Financial Officer
Marketwired - Thu Feb 12, 8:04AM CST
CannaPharmaRx, Inc. (OTCQB: GDHC), the New Jersey-based pharmaceutical company, today announced that Christopher P. Schnittker, CPA has joined the company as its Chief Financial Officer, replacing Gary Herick, who will remain on the Board of Directors and as an employee in the role of Director of Finance. Gary's primary focus will remain on raising capital and investor relations.
CannaPharmaRx Teams Up With The Catalyst Agency to Build and Introduce CMR, a Longitudinal Cannabinoid Medicines Registry Database
ACCESSWIRE - Thu Jan 29, 6:00AM CST
CARNEYS POINT, NJ / ACCESSWIRE / January 29, 2015 / CannaPharmaRx, Inc. (OTCQB: GDHC), the New Jersey-based pharmaceutical company, is launching its proprietary Cannabinoid Medicines Registry(SM) program (CMR).
Cannapharmarx Engages Pharmaceutical Industry Drug Delivery Technology Expert Mario A. Gonzalez, Ph.D.
ACCESSWIRE - Wed Jan 28, 10:41AM CST
CARNEYS POINT, NJ / ACCESSWIRE / January 28, 2015 / CannaPharmaRx, Inc. (OTCQB: GDHC), the New Jersey-based pharmaceutical company, has announced the signing of a consultancy agreement with Mario A. Gonzalez, PhD, President and Chief Executive Officer of P'Kinetics International, Inc., a consulting firm specializing in pharmaceutical product development and pharmacokinetics research.
CannaPharmaRx names Mario A. Gonzalez as drug delivery technology expert
M2 - Wed Jan 28, 5:34AM CST
CannaPharmaRx Inc (OTC:GDHC), a pharmaceutical company focussed on cannabinoid-based therapies, announced on Tuesday the signing of a consultancy agreement with Mario A. Gonzalez, PhD, president and chief executive officer of P'Kinetics International Inc, a consulting firm specialising in pharmaceutical product development and pharmacokinetics research.
CannaPharmaRx names Thomas J. Della-Franco III as new financial controller
M2 - Mon Dec 08, 5:30AM CST
CannaPharmaRx Inc (OTC:GDHC), a pharmaceutical research and discovery company, announced on Friday that it has appointed Thomas J. Della-Franco III as financial controller.
CannapharmaRx (GDHC), Gary Herick sued for self-dealing by new plaintiff
PR Newswire - Tue Nov 25, 7:21AM CST
CannapharmaRx, (stock symbol GDHC), now tangled in a third lawsuit over legal ownership of the corporation. The new plaintiff alleges he is one of the original architects of the CannapharmaRx business and business plan, and claims he was wrongfully "cut out" of the stock ownership and opportunity to build the company.
CannapharmaRx, aka Golden Dragon Holding Company (stock symbol GDHC) Directors Gerald E Crocker, Robert "Bo" Liess, Mat Sherwood and James Smeeding are added to a lawsuit for Conspiracy and other counts
PR Newswire - Thu Nov 20, 2:44PM CST
The Board of Directors of CannapharmaRx, also known as Golden Dragon Holding Company, (stock symbol GDHC), have been added to multiple counts of the complaint filed by Gary M Cohen, the Founder, ex-President, Chief Operating Officer, and member of The Board of Directors, according to the National Association of Cannabis Pharmacy.
